Beta-adrenergic receptor signaling in the heart: role of CaMKII

Michael Grimm1, Joan Heller Brown

  • 1Department of Pharmacology, University of California, San Diego, CA, USA. mgrimm@ucsd.edu

Insights

Calcium/calmodulin-dependent protein kinase II (CaMKII) may mediate some effects of beta-adrenergic receptor (beta-AR) signaling, particularly in heart failure. CaMKII inhibition shows promise for treating heart failure by addressing Ca(2+) handling disturbances.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and protein kinase A (PKA) are key signaling molecules.
  • Both kinases target substrates involved in Ca(2+) homeostasis and gene transcription.
  • Beta-adrenergic receptor (beta-AR) signaling primarily involves PKA, but CaMKII activation by beta-AR stimulation is increasingly recognized.

Purpose of the Study:

  • To review evidence and mechanisms of CaMKII activation by beta-AR stimulation.
  • To explore CaMKII's role in beta-AR regulation of cardiac function.
  • To consider CaMKII's potential therapeutic targeting in heart failure.

Main Methods:

  • Literature review of studies investigating CaMKII and beta-AR signaling.
  • Analysis of experimental data on CaMKII activity in response to beta-AR stimulation.
  • Examination of the impact of CaMKII inhibition or gene deletion on cardiac function and heart failure models.

Main Results:

  • CaMKII is activated by beta-AR stimulation, potentially in parallel or downstream of PKA.
  • While acute beta-AR effects on contractility are minimally affected by CaMKII inhibition, CaMKII is upregulated in heart failure.
  • CaMKII inhibition or gene deletion demonstrates significant benefits in heart failure development and progression.

Conclusions:

  • CaMKII plays a crucial role in the detrimental effects of chronic beta-AR stimulation in heart failure.
  • CaMKII-mediated Ca(2+) handling disturbances may underlie heart failure pathophysiology.
  • Targeting CaMKII represents a promising therapeutic strategy for heart failure.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...